Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids.

Abstract

BACKGROUND:

The stage, when tissues and organs are growing, is very vulnerable to environmental influences, but it's not clear how exposure during this time causes changes to the epigenome and increases the risk of hormone-related illnesses like uterine fibroids (UFs).

METHODS:

Developmental reprogramming of myometrial stem cells (MMSCs), the putative origin from which UFs originate, was investigated in vitro and in the Eker rat model by RNA-seq, ChIP-seq, RRBS, gain/loss of function analysis, and luciferase activity assays.

RESULTS:

When exposed to the endocrine-disrupting chemical (EDC) diethylstilbestrol during Eker rat development, MMSCs undergo a reprogramming of their estrogen-responsive transcriptome. The reprogrammed genes in MMSCs are known as estrogen-responsive genes (ERGs) and are activated by mixed lineage leukemia protein-1 (MLL1) and DNA hypo-methylation mechanisms. Additionally, we observed a notable elevation in the expression of ERGs in MMSCs from Eker rats exposed to natural steroids after developmental exposure to EDC, thereby augmenting estrogen activity.

CONCLUSION:

Our studies identify epigenetic mechanisms of MLL1/DNA hypo-methylation-mediated MMSC reprogramming. EDC exposure epigenetically targets MMSCs and leads to persistent changes in the expression of a subset of ERGs, imparting a hormonal imprint on the ERGs, resulting in a "hyper-estrogenic" phenotype, and increasing the hormone-dependent risk of UFs.

• Authors: Qiwei Yang, Mohamed Ali, Lindsey S Treviño, Aymara Mas, Ayman Al-Hendy
• Journal: Cellular and molecular life sciences : CMLS (Cell Mol Life Sci) Vol. 80 Issue 9 Pg. 274 (Aug 31 2023) ISSN: 1420-9071 [Electronic] Switzerland
• PMID: 37650943 (Publication Type: Journal Article)
• Copyright: © 2023. The Author(s).

Chemical References

• Endocrine Disruptors
• Estrogens
• Myeloid-Lymphoid Leukemia Protein
• DNA

Topics

• Animals
• Rats
• Endocrine Disruptors (toxicity)
• Estrogens
• Biological Assay
• Leiomyoma (chemically induced, genetics)
• Myeloid-Lymphoid Leukemia Protein
• DNA